287
Views
10
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study

, , &
Pages 137-141 | Received 19 Sep 2017, Accepted 30 Oct 2017, Published online: 03 Nov 2017

References

  • Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–656.
  • Centers for Disease Control and Prevention (CDC). Health-related quality of life among adults with arthritis–behavioral risk factor surveillance system, 11 states, 1996-1998. MMWR Morb Mortal Wkly Rep. 2000;49:366–369.
  • Reginster JY. The prevalence and burden of arthritis. Rheumatology Oxford University Press. 2002;41:3–6.
  • Chou CT, Pei L, Chang DM, et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–306.
  • Picavet HSJ, Hazes JMW. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis. 2003;62:644–650.
  • Andrianakos A, Trontzas P, Christoyannis F, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol. 2003;30:1589–1601.
  • Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine. 2013;80:29–33.
  • Wong K, Gladman DD, Husted J, et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 1997;40:1868–1872.
  • Elske Van Den Akker-Van Marle M, Chorus AMJ, Vliet Vlieland TPM, et al. Cost of rheumatic disorders in the Netherlands. Best Pract Res Clin Rheumatol. 2012;26:721–731.
  • Listing J, Kekow J, Manger B, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis. 2015;74:415–421.
  • Coyte PC, Asche CV, Croxford R, et al. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res (Hoboken) John Wiley & Sons, Inc. 1998;11:315–325.
  • March LM, Bachmeier CJM. Economics of osteoarthritis: a global perspective. Occup Heal Ind Med. 1998;3:154.
  • Krishnan E, Lingala B, Bruce B, et al. Disability in rheumatoid arthritis in the era of biological treatments. Ann Rheum Dis. 2012;71:213–218.
  • Salvarani C, Macchioni P, Rossi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991;34:351–356.
  • Salvarani C, Lo Scocco G, Macchioni P, et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol. 1995;22:1499–1503.
  • Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23:819–828.
  • Humphreys JH, Verstappen SMM, Hyrich KL, et al. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register. Rheumatol (United Kingdom). 2013;52:1141–1142.
  • National Institute of Statistics, Italy. Available from: http://demo.istat.it/
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581.
  • Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–2673.
  • Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71:484–492.
  • Gabriel SE, Crowson CS, O’Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 1999;42:415–420.
  • Doran MF, Pond GR, Crowson CS, et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002;46:625–631.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American college of rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006;36:182–188.
  • Carbonell J, Cobo T, Balsa A, et al. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology. 2008;47:1088–1092.
  • Benucci M, Cammelli E, Manfredi M, et al. Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-L Signe). Rheumatol Int. 2008;28(8):777–781.
  • Kaipiainen-Seppänen O. Incidence of psoriatic arthritis in Finland. Br J Rheumatol. 1996;35:1289–1291.
  • Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol. 2000;27:1247–1250.
  • Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28:554–559.
  • Catanoso M, Pipitone N, Salvarani C. Epidemiology of psoriatic arthritis psoriasis. Reumatismo. 2012;64:66–70.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35:1354–1358.
  • Egeberg A, Kristensen LE, Thyssen JP, et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis. 2017;76:1591–1597. [Epub ahead of print].
  • Raheel S, Shbeeb I, Crowson CS, et al. Epidemiology of polymyalgia rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population based study. Arthritis Care Res (Hoboken). 2017 Aug;69(8):1282–1285.
  • Doran MF, Crowson CS, O’Fallon WM, et al. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002;29:1694–1697.
  • Franzén P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol. 1992;19:273–276.
  • Boesen P, Sørensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987;30:294–299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.